120 related articles for article (PubMed ID: 6197464)
1. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
Katz P; Zaytoun AM; Lee JH; Fauci AS
J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
[No Abstract] [Full Text] [Related]
2. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
[TBL] [Abstract][Full Text] [Related]
3. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
[TBL] [Abstract][Full Text] [Related]
4. Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome.
Merino F; Henle W; Ramírez-Duque P
J Clin Immunol; 1986 Jul; 6(4):299-305. PubMed ID: 3018035
[TBL] [Abstract][Full Text] [Related]
5. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.
Seeley J; Svedmyr E; Weiland O; Klein G; Moller E; Eriksson E; Andersson K; van der Waal L
J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974
[No Abstract] [Full Text] [Related]
6. Chediak-Higashi syndrome: immunological responses to Epstein-Barr virus studies in gene heterozygotes.
Merino F; Amesty C; Henle W; Layrisse Z; Bianco N; Ramírez-Duque P
J Clin Immunol; 1986 May; 6(3):242-8. PubMed ID: 3013924
[TBL] [Abstract][Full Text] [Related]
7. [The functional activity of the natural killers in patients with infectious mononucleosis and other viral infections].
Zverkova AS; Faktorova EI
Vrach Delo; 1990 Jun; (6):107-10. PubMed ID: 2399702
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a murine model (beige) for a natural killer cell immunodeficiency in the Chediak-Higashi syndrome of man.
Roder JC
Prog Clin Biol Res; 1982; 94():315-25. PubMed ID: 7122620
[No Abstract] [Full Text] [Related]
9. [Chediak-Higashi syndrome in an adult female].
Utsunomiya A; Saito T; Hanada S; Tin E; Oshige T; Hashimoto S; Hamaguchi Y; Ueno T
Rinsho Ketsueki; 1988 Sep; 29(9):1422-6. PubMed ID: 3216514
[No Abstract] [Full Text] [Related]
10. Further studies of natural killer cell function in Chediak-Higashi patients.
Roder JC; Haliotis T; Laing L; Kozbor D; Rubin P; Pross H; Boxer LA; White JG; Fauci AS; Mostowski H; Matheson DS
Immunology; 1982 Jul; 46(3):555-60. PubMed ID: 6212535
[TBL] [Abstract][Full Text] [Related]
11. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes.
Martín-Fernández JM; Cabanillas JA; Rivero-Carmena M; Lacasa E; Pardo J; Anel A; Ramírez-Duque PR; Merino F; Rodríguez-Gallego C; Regueiro JR
J Leukoc Biol; 2005 May; 77(5):661-8. PubMed ID: 15728247
[TBL] [Abstract][Full Text] [Related]
12. [Specific delayed hypersensitivity to Epstein-Barr virus: in vitro study by leukocyte migration inhibition].
Szigeti R; Timár L; Knoll J; Kuti D; Révész T
Orv Hetil; 1980 May; 121(19):1121-4. PubMed ID: 6251414
[No Abstract] [Full Text] [Related]
13. Long-term T-cell-mediated immunity to Epstein-Barr virus.
Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
[No Abstract] [Full Text] [Related]
14. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
15. [Interferon and natural killer cells].
Saksela E
Duodecim; 1980; 96(16):1061-4. PubMed ID: 6164530
[No Abstract] [Full Text] [Related]
16. [Clinical significance of natural killer cell activity].
Abo T
Nihon Rinsho; 1990 Feb; 48 Suppl():726-9. PubMed ID: 2355603
[No Abstract] [Full Text] [Related]
17. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome?
Rubin CM; Burke BA; McKenna RW; McClain KL; White JG; Nesbit ME; Filipovich AH
Cancer; 1985 Aug; 56(3):524-30. PubMed ID: 2988747
[TBL] [Abstract][Full Text] [Related]
18. A prospective study: evaluation of the antibody-dependent cell-mediated cytotoxicity assay in chronic active Epstein-Barr syndrome.
Waters-Peacocke N; Wray BB; Ades EW
J Clin Lab Immunol; 1988 Sep; 27(1):11-2. PubMed ID: 2855078
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
Nair MP; Gray RH; Boxer LA; Schwartz SA
Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
[TBL] [Abstract][Full Text] [Related]
20. [Severe chronic Epstein-Barr virus infection with natural killer cell defect].
Hartung K; Le Blanc S; Franz A; Jacobs R; Wittekind C; Bornkamm GW; Schmidt RE
Dtsch Med Wochenschr; 1988 Dec; 113(50):1960-3. PubMed ID: 2848676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
